Efficacy and safety of perioperative FLOT (5-FU, LV, oxaliplatin, docetaxel) chemotherapy in gastric and gastroesophageal junction adenocarcinoma: Real-life data from Turkish oncology group
dc.contributor.author | Erol, C. | |
dc.contributor.author | Basoglu, T. | |
dc.contributor.author | Sakin, A. | |
dc.contributor.author | Ozden, E. | |
dc.contributor.author | Cubuk, D. | |
dc.contributor.author | Yumuk, P. F. | |
dc.contributor.author | Dogan, M. | |
dc.date.accessioned | 2024-02-23T14:02:05Z | |
dc.date.available | 2024-02-23T14:02:05Z | |
dc.date.issued | 2021 | |
dc.department | NEÜ | en_US |
dc.description | Congress of the European-Society-for-Medical-Oncology (ESMO) -- SEP 16-21, 2021 -- ELECTR NETWORK | en_US |
dc.description.abstract | [Abstract Not Availabe] | en_US |
dc.description.sponsorship | European Soc Med Oncol,Japanese Soc Med Oncol | en_US |
dc.identifier.doi | 10.1016/j.annonc.2021.08.1514 | |
dc.identifier.endpage | S1058 | en_US |
dc.identifier.issn | 0923-7534 | |
dc.identifier.issn | 1569-8041 | |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | S1058 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.annonc.2021.08.1514 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12452/11579 | |
dc.identifier.volume | 32 | en_US |
dc.identifier.wos | WOS:000700527702418 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.ispartof | Annals Of Oncology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | [Keyword Not Available] | en_US |
dc.title | Efficacy and safety of perioperative FLOT (5-FU, LV, oxaliplatin, docetaxel) chemotherapy in gastric and gastroesophageal junction adenocarcinoma: Real-life data from Turkish oncology group | en_US |
dc.type | Conference Object | en_US |